Cargando…

An Image Fusion System for Estimating the Therapeutic Effects of Radiofrequency Ablation on Hepatocellular Carcinoma

BACKGROUND: During ultrasound-guided radiofrequency ablation (RFA) of hepatocellular carcinoma (HCC), high echoic areas due to RFA-induced microbubbles can help calculate the extent of ablation. However, these areas also decrease visualization of target tumors, making it difficult to assess whether...

Descripción completa

Detalles Bibliográficos
Autores principales:	Toshikuni, Nobuyuki, Matsue, Yasuhiro, Ozaki, Kazuaki, Yamada, Kaho, Hayashi, Nobuhiko, Tsuchishima, Mutsumi, Tsutsumi, Mikihiro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	De Gruyter Open 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5611990/ https://www.ncbi.nlm.nih.gov/pubmed/28959162 http://dx.doi.org/10.1515/raon-2017-0028

Ejemplares similares

Advanced ultrasonography technologies to assess the effects of radiofrequency ablation on hepatocellular carcinoma
por: Toshikuni, Nobuyuki, et al.
Publicado: (2013)

Serum Osteopontin Predicts Degree of Hepatic Fibrosis and Serves as a Biomarker in Patients with Hepatitis C Virus Infection
por: Matsue, Yasuhiro, et al.
Publicado: (2015)

The combination of fatty liver and increased gamma-glutamyl transpeptidase levels as a risk factor for atherosclerotic plaque development in apparently healthy people
por: KINOSHITA, Kaori, et al.
Publicado: (2019)

Comparison of the relationships of alcoholic and nonalcoholic fatty liver with hypertension, diabetes mellitus, and dyslipidemia
por: Toshikuni, Nobuyuki, et al.
Publicado: (2013)

Serum Endocan as a Novel Prognostic Biomarker in Patients with Hepatocellular Carcinoma
por: Ozaki, Kazuaki, et al.
Publicado: (2014)

Associations of Fatty Liver Disease with Hypertension, Diabetes, and Dyslipidemia: Comparison between Alcoholic and Nonalcoholic Steatohepatitis
por: Toshikuni, Nobuyuki, et al.
Publicado: (2017)

MMP‐13 deletion decreases profibrogenic molecules and attenuates N‐nitrosodimethylamine‐induced liver injury and fibrosis in mice
por: George, Joseph, et al.
Publicado: (2017)

Alteration of Trace Elements during Pathogenesis of N-Nitrosodimethylamine Induced Hepatic Fibrosis
por: George, Joseph, et al.
Publicado: (2019)

Molecular mechanisms in the pathogenesis of N-nitrosodimethylamine induced hepatic fibrosis
por: George, Joseph, et al.
Publicado: (2019)

Acetaldehyde-Derived Advanced Glycation End-Products Promote Alcoholic Liver Disease
por: Hayashi, Nobuhiko, et al.
Publicado: (2013)

Surgical implantation of human adipose derived stem cells attenuates experimentally induced hepatic fibrosis in rats
por: Nomura, Masateru, et al.
Publicado: (2022)

Laparoscopic radiofrequency ablation versus percutaneous radiofrequency ablation for subphrenic hepatocellular carcinoma
por: Kwak, Min Hwan, et al.
Publicado: (2022)

Radiofrequency Thermal Ablation of Hepatocellular Carcinomas
por: Lim, Hyo Keun
Publicado: (2000)

Therapeutic Efficacy of Percutaneous Radiofrequency Ablation versus Microwave Ablation for Hepatocellular Carcinoma
por: Zhang, Lei, et al.
Publicado: (2013)

Use of radiofrequency ablation in the treatment of hepatocellular carcinoma: Experience of ablation protocols
por: MASAYOSHI, TAKAHASHI, et al.
Publicado: (2012)

Efficacy and Safety of Fusion Imaging in Radiofrequency Ablation of Hepatocellular Carcinoma Compared to Ultrasound: A Meta-Analysis
por: Jie, Tao, et al.
Publicado: (2021)

Radiofrequency Ablation of Hepatocellular Carcinoma: A Literature Review
por: Minami, Yasunori, et al.
Publicado: (2011)

Recent Advances in Radiofrequency Ablation for the Management of Hepatocellular Carcinoma
por: Himoto, Takashi, et al.
Publicado: (2012)

An Overview of Hepatocellular Carcinoma After Insufficient Radiofrequency Ablation
por: Guo, Yusheng, et al.
Publicado: (2022)

Surgical Resection or Radiofrequency Ablation for Small Hepatocellular Carcinoma
por: Feng, Qingbo, et al.
Publicado: (2022)

Surgical Resection or Radiofrequency Ablation for Small Hepatocellular Carcinoma
por: Kawaguchi, Yoshikuni, et al.
Publicado: (2023)

Microwave ablation is as effective as radiofrequency ablation for very-early-stage hepatocellular carcinoma
por: Xu, Yun, et al.
Publicado: (2017)

Therapeutic efficacy comparison of radiofrequency ablation in hepatocellular carcinoma and metastatic liver cancer
por: LIU, JING, et al.
Publicado: (2014)

Combined Transarterial Chemoembolization and Radiofrequency Ablation for Hepatocellular Carcinoma Infeasible for Ultrasound-Guided Percutaneous Radiofrequency Ablation: A Comparative Study with General Ultrasound-Guided Radiofrequency Ablation Outcomes
por: Cha, Dong Ik, et al.
Publicado: (2023)

Minimal ablative margin (MAM) assessment with image fusion: an independent predictor for local tumor progression in hepatocellular carcinoma after stereotactic radiofrequency ablation
por: Laimer, Gregor, et al.
Publicado: (2020)

Survival rates of early-stage HCV-related liver cirrhosis patients without hepatocellular carcinoma are decreased by alcohol
por: Yamada, Masayoshi, et al.
Publicado: (2011)

Management of Spontaneously Ruptured Hepatocellular Carcinomas in the Radiofrequency Ablation Era
por: Cheung, Tan To, et al.
Publicado: (2014)

Role of radiofrequency ablation in unresectable hepatocellular carcinoma: An Indian experience
por: Kalra, Naveen, et al.
Publicado: (2013)

EUS-guided radiofrequency ablation of a hepatocellular carcinoma of the liver
por: Attili, Fabia, et al.
Publicado: (2018)

Aggressive tumor recurrence after radiofrequency ablation for hepatocellular carcinoma
por: Kang, Tae Wook, et al.
Publicado: (2017)

Features of extrahepatic metastasis after radiofrequency ablation for hepatocellular carcinoma
por: Yoon, Jae H, et al.
Publicado: (2020)

Simultaneous transarterial chemoembolization and radiofrequency ablation for large hepatocellular carcinoma
por: Duan, Feng, et al.
Publicado: (2020)

The Combination Strategy of Transarterial Chemoembolization and Radiofrequency Ablation or Microwave Ablation against Hepatocellular Carcinoma
por: Xu, Zhentian, et al.
Publicado: (2019)

Radiofrequency Ablation with the Real-Time Virtual Sonography System for Treating Hepatocellular Carcinoma Difficult to Detect by Ultrasonography
por: Kawasoe, Hiroaki, et al.
Publicado: (2007)

Percutaneous Radiofrequency Ablation for the Hepatocellular Carcinoma Abutting the Diaphragm: Assessment of Safety and Therapeutic Efficacy
por: Kang, Tae Wook, et al.
Publicado: (2009)

Application and Evaluation of a 64-Slice CT Three-Dimensional Fusion Technique in the Determination of the Effective Ablation Margin after Radiofrequency Ablation of Hepatocellular Carcinoma
por: Du, Haihao, et al.
Publicado: (2022)

Usefulness of Real-Time 4D Ultrasonography during Radiofrequency Ablation in a Case of Hepatocellular Carcinoma
por: Hotta, Naoki, et al.
Publicado: (2011)

Radiofrequency ablation of very-early-stage hepatocellular carcinoma inconspicuous on fusion imaging with B-mode US: value of fusion imaging with contrast-enhanced US
por: Min, Ji Hye, et al.
Publicado: (2014)

Feeding artery ablation before radiofrequency ablation for hepatocellular carcinoma may reduce critical recurrence
por: Shimizu, Ryo, et al.
Publicado: (2021)

Efficacy of microwave ablation versus radiofrequency ablation for hepatocellular carcinoma: a propensity score analysis
por: Suwa, Kanehiko, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_dj508euc2g37p2d4p4fm29i899